/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction
Event: Heart Failure 2019
Topic: Pharmacotherapy
Session: Moderated Poster Session - Basic Science
ESC 365 is supported by
